The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer

International Journal of Gynecological Cancer

Volumn 21, Issue 1, 2011, Pages 92-99

  Yin, Mingzhu ^a   Zhao, Falin ^a,b   Lou, Ge ^a   Zhang, Haiyu ^b   Sun, Meng ^b   Li, Cong ^a   Hou, Yan ^b   Li, Xia ^a   Meng, Fanling ^a   Chen, Xiuwei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Cervical carcinoma; Concurrent chemoradiotherapy; Neoadjuvant chemotherapy; Radical hysterectomy; Survival

Indexed keywords

BLEOMYCIN; CISPLATIN; PACLITAXEL; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; RISK FACTOR; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; VINBLASTINE; YOUNG ADULT;

EID: 79951496644     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181fe8b6e     Document Type: Article

References (20)

1. Choi CH, Kim TJ, Lee JW, et al. Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma. Gynecol Oncol. 2007;104:64-69. (Pubitemid 46054117)
2. Benedetti Panici P, Bellati F, Pastore M, et al. An update in neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol. 2007;107:S20-S22. (Pubitemid 47483879)
3. Napolitano U, Imperato F, Mossa B, et al. Therole of neoadjuvant chemotherapy for squamous cell cervical cancer (IB-IIIB): a long-term randomized trial. Eur J Gynaecol Oncol. 2003;24:51-59. (Pubitemid 36268188)
4. Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005;CD002225.
5. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340: 1144-1153. (Pubitemid 29177873)
6. Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20:179-188. (Pubitemid 34032610)
7. Long HJ, Bundy BN, Grendys EC, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol. 2005;23:4626-4633. (Pubitemid 46224065)
8. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol. 2003;14:1278-1284. (Pubitemid 37039056)
9. Behtash N, Nazari Z, Ayatollahi H, et al. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer. Eur J Surg Oncol. 2006;32:1226-1230. (Pubitemid 44774409)
10. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1974;44:265-272.
11. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization; 1979.
12. Duenas-Gonzalez A, Cetina L, Mariscal I, et al. Modern management of locally advanced cervical carcinoma. Cancer Treat Rev. 2003;29:389-399. (Pubitemid 37185105)
13. Eddy GL Sr. Neoadjuvant chemotherapy before surgery in cervical cancer. J Natl Cancer Inst Monogr. 1996;21:93-99.
14. Di Vagno G, Cormio G, Pignata S, et al. Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study. Int J Gynecol Cancer. 2003;13:308-312. (Pubitemid 38222579)
15. Benedet J, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri: FIGO annual report on the results of treatment in gynaecological cancer. J Epidemiol Biost. 1998;3:5-34.
16. Mori T, Hosokawa K, Sawada M, et al. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results. Int J Gynecol Cancer. 2010;20:611-616.
17. Park DC, Suh MJ, Yeo SG. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results. Int J Gynecol Cancer. 2009;19:943-947.
18. Benedetti Panici P, Greggi S, Baiocchi G, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer. 1991;67:372-379.
19. Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer. 2000;10:305-312.
20. Saito T, Takehara M, Lee R, et al. Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinomaVa preliminary study. Int J Gynecol Cancer. 2004;14:483-490. (Pubitemid 38747429)